Trial intelligence / Profile preview

Prophylactic amoxicillin/clavulanic acid during chemoradiotherapy to prevent aspiration pneumonia in locally advanced head and neck cancer

2011-000076-33Phase 2Completed

Sponsor
Radboud University Medical Center
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of amoxicillin + clavulanate in head and neck cancer (HNC), sponsored by Radboud University Medical Center. Primary endpoint: Number of definite and/or suspected pneumonia. Started May 2011; status: completed.

02

Drugs

amoxicillin + clavulanate
03

Conditions

head and neck cancer (HNC)

Beyond the preview

Go deeper on 2011-000076-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000076-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call